This is a firm fixed-price delivery order contract awarded by the Veterans Integrated Service Network 15 (VISN 15), a component of the U.S. Department of Veterans Affairs (VA), to Sofie CO. (doing business as IBA Molecular) for the supply of PYLARIFY F-18 DCFPYL, a radiopharmaceutical used for prostate cancer detection. The contract has a ceiling value of $1,172,834.00 and an ultimate completion date of May 31, 2026. Sofie CO. is a for-profit organization specializing in the development,...
The federal contract award is for the supply of RADIOPHARMACEUTICAL NEEDED FOR PROSTATE CANCER PATIENT WITH METASTATIC LESIONS AFTER DEFINITE TREATMENT. The contract was awarded to Sofie CO., doing business as IBA Molecular, a for-profit organization specializing in the development and supply of molecular diagnostics and radiopharmaceuticals. The $28,869.76 firm fixed-price contract is a BPA Call awarded by the Defense Health Agency (DHA), a defense agency, to support medical imaging and...
This federal contract award, valued at $25,261.04, was made by the Defense Health Agency (DHA) to Sofie CO., doing business as IBA Molecular, for the provision of radiopharmaceuticals needed for the treatment of prostate cancer patients with metastatic lesions. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price pricing type and an ultimate completion date of September 30, 2025. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a for-profit organization...
This is a federal contract award to Sofie CO., doing business as IBA Molecular, a subsidiary of Sofie Biosciences, Inc. The $1,725,507.80 fixed-price contract was awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) for the supply of FDG and NEURACEQ radiopharmaceuticals. This contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a focus on...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
This federal contract award, valued at $822,788.16, was issued by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular. The contract is a firm fixed-price purchase order for the radiopharmaceutical product PYLARIFY, which is used for prostate cancer detection. Sofie CO. is a subsidiary of Sofie Biosciences, Inc., a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with a...
This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PET radiopharmaceuticals, which are specialized imaging agents used for medical diagnostics and cancer treatment. The award, valued at $188,258.00, is a delivery order under a larger $5.86 million Indefinite Delivery Vehicle (IDV) contract with the VA's Veterans Integrated Service Network (VISN) 15 for the...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has a ceiling value of $32,478.48 and a period of performance through September 30, 2024. This award is not associated with a set-aside program. Sofie CO. is an established...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 2 (VISN 2), part of the U.S. Department of Veterans Affairs (VA), to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of emergency radiopharmaceuticals, with a ceiling value of $94,702.70 and a completion date of April 15, 2022. The contract does not have a set-aside designation. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $10,826.16 contract is for the supply of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has an ultimate completion date of September 30, 2024. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and...